Literature DB >> 11416693

Direct vasodilators and their role in hypertension management: minoxidil.

D A Sica1, T W Gehr.   

Abstract

Minoxidil is a direct vasodilator that has been in use for over two decades. It is used primarily to reduce blood pressure in hypertensives who have been poorly controlled on various multidrug regimens. Although minoxidil is extremely effective, its usefulness is limited by its tendency to increase the pulse rate and to trigger salt and water retention. The latter may be incapacitating in some patients. Therefore, minoxidil is typically administered with both a diuretic and an agent that can control the pulse rate, such as a beta blocker. Minoxidil has several other side effects that may limit its use, including hypertrichosis, aggravation of myocardial ischemia and/or left ventricular hypertrophy, and (infrequently) pericardial effusions. If a patient's hypertensive pattern is sufficiently severe to warrant contemplation of minoxidil therapy, referring the patient to a hypertension specialist should be strongly considered. (c) 2001 by LeJacq Communications, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416693      PMCID: PMC8099328          DOI: 10.1111/j.1524-6175.2001.00455.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  39 in total

1.  Hair loss with minoxidil withdrawal.

Authors:  B J Kidwai; M George
Journal:  Lancet       Date:  1992-09-05       Impact factor: 79.321

2.  Minoxidil for severe hypertension after failure of other hypotensive drugs.

Authors:  B L Devine; R Fife; P M Trust
Journal:  Br Med J       Date:  1977-09-10

3.  Pharmacokinetics of minoxidil in patients with cirrhosis and healthy volunteers.

Authors:  M H Adams; W J Poynor; W R Garnett; H T Karnes; J J Ferry; K K Ryan; M A Sarkar
Journal:  Biopharm Drug Dispos       Date:  1998-11       Impact factor: 1.627

4.  Tissue distribution and hypotensive effects of minoxidil in normotensive rats.

Authors:  R G Pluss; J Orcutt; C A Chidsey
Journal:  J Lab Clin Med       Date:  1972-04

5.  Topical minoxidil: cardiac effects in bald man.

Authors:  F H Leenen; D L Smith; W P Unger
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

Review 6.  Minoxidil: a review of its pharmacological properties and therapeutic use.

Authors:  V M Campese
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 7.  Minoxidil and the treatment of severe hypertension.

Authors:  W A Pettinger
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

8.  Rapid control of severe hypertension with minoxidil.

Authors:  M A Alpert; J H Bauer
Journal:  Arch Intern Med       Date:  1982-11

9.  Minoxidil and pericardial effusion: an idiosyncratic reaction.

Authors:  M J Reichgott
Journal:  Clin Pharmacol Ther       Date:  1981-07       Impact factor: 6.875

10.  Hypertrichosis due to minoxidil.

Authors:  J L Burton; A Marshall
Journal:  Br J Dermatol       Date:  1979-11       Impact factor: 9.302

View more
  3 in total

Review 1.  [Kidney and hypertension].

Authors:  I Quack; L C Rump
Journal:  Internist (Berl)       Date:  2009-04       Impact factor: 0.743

2.  Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.

Authors:  Heiko M Mundt; Matthias Matenaer; Alexander Lammert; Uwe Göttmann; Bernhard K Krämer; Rainer Birck; Urs Benck
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

Review 3.  Calcium channel blocker-related periperal edema: can it be resolved?

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.